Related Experiment Video
Updated: May 16, 2026

06:52
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
Multiplex networks-based directed graph neural network for cancer driver gene identification.
1College of Information Science and Engineering, Hunan Normal University, Changsha, China.
Plos Computational Biology
|May 14, 2026
Summary
This study introduces a novel multiplex network-based directed graph neural network (MNDGNN) to identify cancer driver genes. The method improves prediction accuracy by integrating multi-omics data and addressing data imbalance for better precision oncology insights.
Area of Science:
- Genomics
- Computational Biology
- Bioinformatics
Background:
- Identifying cancer driver genes is vital for precision oncology.
- Current methods often use single networks, limiting comprehensive gene relationship analysis.
- Integrating multiplex networks with multi-omics data offers a richer view of gene interactions.
Purpose of the Study:
- To develop a novel method for identifying cancer driver genes.
- To address limitations of existing methods, including label scarcity and class imbalance.
- To leverage multiplex networks and multi-omics data for improved gene representation.
Main Methods:
- Proposed a multiplex networks-based directed graph neural network (MNDGNN).
- Utilized directed graph convolution to integrate neighbor and degree diversity from multiplex networks.
- Incorporated data augmentation (positive-sample augmentation and negative-sample inference) to mitigate label scarcity.
Main Results:
- MNDGNN demonstrated superior predictive performance and robustness compared to state-of-the-art methods.
- Predicted cancer driver genes were significantly enriched in cancer-related pathways.
- Identified extensive interactions between predicted genes and known cancer drivers.
Conclusions:
- The MNDGNN model effectively identifies cancer driver genes by integrating multiplex networks and multi-omics data.
- The approach offers a new perspective for cancer driver gene discovery.
- Findings support the design of novel therapeutic strategies in precision oncology.
